|
24.06.25 - 15:33
|
Petros PACE Finance Announces Executive Leadership Transition (PR Newswire)
|
|
Kevin McMeen, MidCap Financial Co-Founder, to Assume Role of President and CEO Co-Founder and CEO Mansoor Ghori and Co-Founder and CFO Jim Stanislaus to Depart at Year End AUSTIN, Texas, June 24, 2025 /PRNewswire/ -- Petros PACE Finance (Petros), one of the largest C-PACE providers in the......
|
|
|
|
04.06.25 - 22:12
|
NeuroPace Secures Up to $75 Million in Debt Financing (GlobeNewswire EN)
|
|
MOUNTAIN VIEW, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company has entered into a new $75 million credit facility with MidCap Financial, consisting of a $60 million term loan and a $15 million revolving credit facility. Proceeds from the new term loan were used to fully repay NeuroPace's term loan with CRG Partners IV, L.P., with proceeds of the new revolving credit facility available for working capital needs and other corporate purposes....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09.03.25 - 21:18
|
XFRA : DIVIDEND/INTEREST INFORMATION - 11.03.2025 - US03761U5020 (XETRA)
|
|
Das Instrument 55O1 US03761U5020 MIDCAP FINANCIAL INVEST. EQUITY wird cum Dividende/Zinsen gehandelt am 10.03.2025 und ex Dividende/Zinsen am 11.03.2025
The instrument 55O1 US03761U5020 MIDCAP FINANCIAL INVEST. EQUITY has its pre-dividend/interest day on 10.03.2025 and its ex-dividend/interest day on 11.03.2025...
|
|
|